Product
EC regimen
Aliases
Epirubicin + Cyclophosphamide
1 clinical trial
2 indications
Indication
NeutropeniaIndication
Breast CancerClinical trial
A Single-Center, Open-Label, Dose-Escalation Phase I Clinical Trial of Recombinant Human Granulocyte Colony Stimulating Factor-Fc Fusion Protein for Injection as an Adjuvant to Chemotherapy in Subjects With Breast CancerStatus: Completed, Estimated PCD: 2013-12-01